Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubin Minhas

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|June 10, 2006
NICE work: level playing field requires transparencyRubin Minhas
BMJ (Clinical Research Ed.)|December 13, 2006
How much will Herceptin really cost? The money is already thereRubin Minhas
BMJ (Clinical Research Ed.)|August 7, 2014
Disclosure should strengthen governance at multiple pointsRubin Minhas
International Journal of Clinical Practice|December 23, 2003
Statins: is OTC actually OTT?Rubin Minhas
International Journal of Clinical Practice|January 19, 2007
Statin utilisation--recognising the role of the invisible handRubin Minhas
Journal of the Royal Society of Medicine|April 8, 2009
Letter from America: the political economics of US healthcare reformRubin Minhas, Claus Wendt
Journal of the Royal Society of Medicine|January 26, 2012
Explanatory models are needed to integrate RCT and observational data with the patient's unique biologyVijay Sharma, Rubin Minhas
Journal of the Royal Society of Medicine|September 10, 2008
From rationing to rational: the evolving status of NICERubin Minhas, Kiran Cr Patel
Journal of the Royal Society of Medicine|May 2, 2007
The Office of Fair Trading report: a prescription for value-based drug pricingRubin Minhas, James C Moon
Journal of Clinical Epidemiology|September 6, 2011
Strength of evidence and handling uncertainty: practical considerations and general observationsMike Bedford, Karen Pettersen, Rubin Minhas
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|June 10, 2006
NICE work: level playing field requires transparencyRubin Minhas
BMJ (Clinical Research Ed.)|December 13, 2006
How much will Herceptin really cost? The money is already thereRubin Minhas
BMJ (Clinical Research Ed.)|August 7, 2014
Disclosure should strengthen governance at multiple pointsRubin Minhas
International Journal of Clinical Practice|December 23, 2003
Statins: is OTC actually OTT?Rubin Minhas
International Journal of Clinical Practice|January 19, 2007
Statin utilisation--recognising the role of the invisible handRubin Minhas
Journal of the Royal Society of Medicine|April 8, 2009
Letter from America: the political economics of US healthcare reformRubin Minhas, Claus Wendt
Journal of the Royal Society of Medicine|January 26, 2012
Explanatory models are needed to integrate RCT and observational data with the patient's unique biologyVijay Sharma, Rubin Minhas
Journal of the Royal Society of Medicine|September 10, 2008
From rationing to rational: the evolving status of NICERubin Minhas, Kiran Cr Patel
Journal of the Royal Society of Medicine|May 2, 2007
The Office of Fair Trading report: a prescription for value-based drug pricingRubin Minhas, James C Moon
Journal of Clinical Epidemiology|September 6, 2011
Strength of evidence and handling uncertainty: practical considerations and general observationsMike Bedford, Karen Pettersen, Rubin Minhas
Pageof 3